Valion Bio, Inc. (VBIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
VBIO price, last 12 months
Key stats
- Previous close
- $0.5024
- Open
- $0.5101
- Day range
- $0.4950 – $0.5470
- 52-week range
- $0.4715 – $32.50
- Volume
- 424.2K
- Avg volume (20 days)
- 1.1M
- Market cap
- $1.1M
Performance
Technicals and fundamentals
About Valion Bio, Inc.
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.1M